In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI

NCT03179449 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Accrual Factor

Conditions

Childhood Brain Neoplasm

Interventions

DIAGNOSTIC_TEST: Diagnostic (ferumoxytol-enhanced MRI)
PROCEDURE: Surgery
DRUG: Ferumoxytol
OTHER: Tissue Analysis

Sponsor

Michael Iv

Collaborators

[object Object]